+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Genetic Biomarkers and Diagnostic Techniques · Registering as Listener

ICGBDT
📅 25 – 26 Feb 2027 📍 Munich, Germany 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Genetic Biomarkers and Diagnostic Techniques
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9

This track will explore the latest discoveries in genetic biomarkers and their implications for disease diagnosis and treatment. Emphasis will be placed on innovative approaches to biomarker identification and validation.

This session will focus on cutting-edge molecular diagnostic techniques and their applications in clinical settings. Participants will discuss the integration of these techniques into routine diagnostics and their impact on patient outcomes.

This track will cover the development and application of genomic assays in clinical genomics. Discussions will include the challenges and opportunities presented by these assays in the context of personalized medicine.

This session will address the methodologies and technologies used in biomarker discovery and validation. Emphasis will be placed on the importance of robust validation processes to ensure clinical applicability.

This track will examine the role of predictive and prognostic markers in the management of various diseases. Participants will discuss how these markers can inform treatment decisions and improve patient outcomes.

This session will highlight the use of high-throughput screening technologies in the identification of novel biomarkers. The focus will be on innovative applications and the potential for accelerating biomarker discovery.

This track will explore the emerging field of liquid biopsy and its implications for non-invasive diagnostics. Discussions will include the technical challenges and clinical applications of liquid biopsy in various diseases.

This session will focus on the latest techniques for mutation detection in genomic studies. Participants will discuss the significance of these techniques in understanding disease mechanisms and treatment responses.

This track will examine the development and application of gene panels in clinical practice. Emphasis will be placed on their role in personalized medicine and the challenges associated with their implementation.

This session will focus on the discovery and application of protein biomarkers in disease diagnosis and monitoring. Participants will discuss the technological advancements that facilitate protein biomarker research.

This track will explore the role of therapeutic biomarkers in the development of targeted therapies. Discussions will include the implications of these biomarkers for treatment efficacy and patient stratification.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED